JPWO2022173033A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022173033A5
JPWO2022173033A5 JP2022580703A JP2022580703A JPWO2022173033A5 JP WO2022173033 A5 JPWO2022173033 A5 JP WO2022173033A5 JP 2022580703 A JP2022580703 A JP 2022580703A JP 2022580703 A JP2022580703 A JP 2022580703A JP WO2022173033 A5 JPWO2022173033 A5 JP WO2022173033A5
Authority
JP
Japan
Prior art keywords
methyl
cyclopropyl
oxy
diazabicyclo
indazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022580703A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022173033A1 (cg-RX-API-DMAC7.html
JP7725511B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/005583 external-priority patent/WO2022173033A1/ja
Publication of JPWO2022173033A1 publication Critical patent/JPWO2022173033A1/ja
Publication of JPWO2022173033A5 publication Critical patent/JPWO2022173033A5/ja
Application granted granted Critical
Publication of JP7725511B2 publication Critical patent/JP7725511B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022580703A 2021-02-15 2022-02-14 4-アミノキナゾリン化合物 Active JP7725511B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021021684 2021-02-15
JP2021021684 2021-02-15
PCT/JP2022/005583 WO2022173033A1 (ja) 2021-02-15 2022-02-14 4-アミノキナゾリン化合物

Publications (3)

Publication Number Publication Date
JPWO2022173033A1 JPWO2022173033A1 (cg-RX-API-DMAC7.html) 2022-08-18
JPWO2022173033A5 true JPWO2022173033A5 (cg-RX-API-DMAC7.html) 2024-02-08
JP7725511B2 JP7725511B2 (ja) 2025-08-19

Family

ID=82838845

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022580703A Active JP7725511B2 (ja) 2021-02-15 2022-02-14 4-アミノキナゾリン化合物

Country Status (12)

Country Link
US (1) US20240150366A1 (cg-RX-API-DMAC7.html)
EP (1) EP4293025B1 (cg-RX-API-DMAC7.html)
JP (1) JP7725511B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230145360A (cg-RX-API-DMAC7.html)
CN (1) CN116867788B (cg-RX-API-DMAC7.html)
AU (1) AU2022219651A1 (cg-RX-API-DMAC7.html)
CA (1) CA3211110A1 (cg-RX-API-DMAC7.html)
ES (1) ES3054794T3 (cg-RX-API-DMAC7.html)
MX (1) MX2023009520A (cg-RX-API-DMAC7.html)
PL (1) PL4293025T3 (cg-RX-API-DMAC7.html)
SA (1) SA523450286B1 (cg-RX-API-DMAC7.html)
WO (1) WO2022173033A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7629580B1 (ja) 2022-01-21 2025-02-13 ユーシノヴァ・ファーマシューティカルズ・リミテッド ベンゾピリミジン化合物及びその使用
CA3255513A1 (en) * 2022-03-11 2025-03-04 Astellas Pharma Inc. HETEROCYCLIC COMPOUND TO INDUCE DETERIORATION OF G12D MUTATION KRAS PROTEIN
EP4568674A1 (en) * 2022-08-12 2025-06-18 Astellas Pharma Inc. Combination of anticancer agents comprising a bifunctional compound with g12d mutant kras inhibitory activity
AU2023322690A1 (en) * 2022-08-12 2025-03-20 Astellas Pharma Inc. Anti cancer combinations comprising chemotherapy
WO2024188281A1 (zh) * 2023-03-13 2024-09-19 南京明德新药研发有限公司 含喹唑啉结构的化合物及其应用
WO2025052649A1 (ja) * 2023-09-08 2025-03-13 アステラス製薬株式会社 単一の軸不斉化合物の選択的製造法
US20250109147A1 (en) 2023-09-08 2025-04-03 Gilead Sciences, Inc. Kras g12d modulating compounds
US20250114346A1 (en) 2023-10-09 2025-04-10 Incyte Corporation Combination therapy using a kras g12d inhibitor and pd-1 inhibitor or pd-l1 inhibitor
KR20260110993A (ko) 2023-10-09 2026-07-14 인사이트 코포레이션 Kras g12d 억제제 및 egfr 억제제를 포함하는 암 치료용 조합
US20260137674A1 (en) 2024-10-23 2026-05-21 Incyte Corporation Combination therapy using a kras g12d inhibitor, and a nucleoside analog, and/or a microtubule inhibitor
WO2026090333A1 (en) 2024-10-23 2026-04-30 Incyte Corporation Combination using a kras g12d inhibitor and chemotherapy combinations as well as their use in the treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10011600B2 (en) 2014-09-25 2018-07-03 Araxes Pharma Llc Methods and compositions for inhibition of Ras
WO2016049565A1 (en) 2014-09-25 2016-03-31 Araxes Pharma Llc Compositions and methods for inhibition of ras
WO2017172979A1 (en) * 2016-03-30 2017-10-05 Araxes Pharma Llc Substituted quinazoline compounds and methods of use
JOP20190186A1 (ar) * 2017-02-02 2019-08-01 Astellas Pharma Inc مركب كينازولين
CN114222743A (zh) * 2019-08-16 2022-03-22 劲方医药科技(上海)有限公司 氧代六元环并嘧啶类化合物,其制法与医药上的用途
CN114615981B (zh) 2019-08-29 2024-04-12 米拉蒂治疗股份有限公司 Kras g12d抑制剂
WO2021106231A1 (en) * 2019-11-29 2021-06-03 Taiho Pharmaceutical Co., Ltd. A compound having inhibitory activity against kras g12d mutation

Similar Documents

Publication Publication Date Title
CN115956080B (zh) 双环化合物,包含其的组合物及其应用
CN111511738B (zh) 杂芳类衍生物调节剂、其制备方法和应用
US8962596B2 (en) 5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases
JP7725511B2 (ja) 4-アミノキナゾリン化合物
JP6306049B2 (ja) A2aアンタゴニスト特性を有するヘテロビシクロ−置換−[1,2,4]トリアゾロ[1,5−c]キナゾリン−5−アミン化合物
BR112021001292A2 (pt) compostos heterobicíclicos para inibir a atividade de shp2
IL276232B2 (en) Pyrazine derivatives, pharmaceutical compositions comprising them and their use for treating diseases
JP7482116B2 (ja) モノアシルグリセロールリパーゼ調節因子
US11993601B2 (en) Monoacylglycerol lipase modulators
JP7254076B2 (ja) 置換ヘテロアリール化合物及び使用方法
WO2025194057A1 (en) Macrocyclic compounds as modulators of kras and uses thereof
WO2025194054A1 (en) Spirocyclic compounds as modulators of kras and uses thereof
WO2025230862A1 (en) Macrocyclic amino compounds as modulators of kras and uses therof
EP4665734A1 (en) Cyclin-dependent kinase (cdk2) inhibitors
WO2025240582A1 (en) Macrocyclic compounds as modulators of kras and uses thereof
US20240238425A1 (en) HSD17B13 Inhibitors and/or Degraders
RU2023123745A (ru) Соединение 4-аминохиназолина
CN117897159A (zh) 杂环化合物及使用方法
CN117835976A (zh) 杂环化合物及使用方法
HK40028822B (en) Heteroaromatic derivatives for use as regulator, preparation method therefor and use thereof
HK1223089B (en) Kinase inhibitor and use thereof
HK1223089A1 (zh) 激酶抑制剂及其用途